Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Spotify
SPOT
|
+$770M |
| 2 |
RingCentral
RNG
|
+$662M |
| 3 |
CrowdStrike
CRWD
|
+$637M |
| 4 |
Teladoc Health
TDOC
|
+$614M |
| 5 |
PayPal
PYPL
|
+$574M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.08B |
| 2 |
Salesforce
CRM
|
+$738M |
| 3 |
Tesla
TSLA
|
+$488M |
| 4 |
Microsoft
MSFT
|
+$453M |
| 5 |
Corpay
CPAY
|
+$436M |
Sector Composition
| 1 | Technology | 32.49% |
| 2 | Consumer Discretionary | 20.28% |
| 3 | Communication Services | 13.08% |
| 4 | Healthcare | 12.66% |
| 5 | Financials | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Inspire Medical Systems
INSP
$2.47B
| $19.4M | 0.02% |
+222,465
| New | +$19.4M |
|
302
Gossamer Bio
GOSS
$605M
| $19.1M | 0.02% |
1,471,308
+761,875
| +107% | +$9.9M |
|
|
NVRO
303
DELISTED
NEVRO CORP.
NVRO
| $19.1M | 0.02% |
+160,077
| New | +$19.1M |
|
|
DOC
304
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $19M | 0.02% |
1,082,595
+946,075
| +693% | +$16.6M |
|
305
Agios Pharmaceuticals
AGIO
$2.12B
| $18.9M | 0.02% |
353,117
-199,612
| -36% | -$10.7M |
|
306
First Bancorp
FBNC
$2.3B
| $18.7M | 0.02% |
747,025
-15,489
| -2% | -$388K |
|
307
National Vision
EYE
$1.86B
| $18.7M | 0.02% |
612,545
+98,287
| +19% | +$3M |
|
308
TFI International
TFII
$7.9B
| $18.6M | 0.02% |
524,210
+106,068
| +25% | +$3.76M |
|
309
Black Diamond Therapeutics
BDTX
$174M
| $18.1M | 0.02% |
428,806
+2,268
| +0.5% | +$95.6K |
|
310
Avantor
AVTR
$8.95B
| $18.1M | 0.02% |
1,063,377
+315,000
| +42% | +$5.35M |
|
|
FOCS
311
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $17.9M | 0.02% |
542,240
-6,000
| -1% | -$198K |
|
312
Ferrari
RACE
$85.3B
| $17.7M | 0.02% |
103,721
+42,118
| +68% | +$7.2M |
|
|
AMK
313
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $17.7M | 0.02% |
649,183
+142,862
| +28% | +$3.9M |
|
314
BHP
BHP
$138B
| $17M | 0.02% |
382,863
+2,244
| +0.6% | +$99.6K |
|
315
Targa Resources
TRGP
$34.5B
| $16.6M | 0.02% |
829,439
+319,004
| +62% | +$6.4M |
|
316
First Foundation Inc
FFWM
$493M
| $16.6M | 0.02% |
1,017,805
+232,593
| +30% | +$3.8M |
|
317
Alexandria Real Estate Equities
ARE
$14.6B
| $16.6M | 0.02% |
102,362
-2,360
| -2% | -$383K |
|
318
Enerpac Tool Group
EPAC
$2.29B
| $16.4M | 0.01% |
930,029
-42,259
| -4% | -$744K |
|
319
ProQR Therapeutics
PRQR
$245M
| $16M | 0.01% |
2,625,514
+13,208
| +0.5% | +$80.3K |
|
320
Apollo Global Management
APO
$76.9B
| $15.9M | 0.01% |
+318,102
| New | +$15.9M |
|
321
Lamb Weston
LW
$8.02B
| $15.7M | 0.01% |
245,174
-195
| -0.1% | -$12.5K |
|
322
Kinross Gold
KGC
$27.5B
| $15.4M | 0.01% |
2,131,887
+45,310
| +2% | +$327K |
|
323
Lazard
LAZ
$5.3B
| $15.4M | 0.01% |
536,863
-86,450
| -14% | -$2.48M |
|
324
Vodafone
VOD
$28.4B
| $15.2M | 0.01% |
952,951
+55,889
| +6% | +$891K |
|
325
HealthEquity
HQY
$8.02B
| $15.1M | 0.01% |
257,032
-8,923
| -3% | -$524K |
|